Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/MEDP
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Medpace Holdings Inc (MEDP) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

MEDP trades at $624.18, up 0.33% on the day, with a bullish technical outlook supported by moving averages and strong support at $616. The company reported robust earnings, beating estimates in Q4 2025, Q1 2026, and Q2 2026, with revenue of $2.53B and net income of $451.12M in 2025. Recent news highlights CEO stock sales and institutional activity, while Q3 2026 results are anticipated on October 21, 2026.
MEDP offers growth potential with consistent earnings beats and a high ROE of 162.15%, but risks include elevated valuation ratios like a P/E of 36.67 and insider selling. Analyst consensus is cautious with 78.95% hold ratings, and the stock faces competition in medical services. Investors should weigh strong fundamentals against valuation concerns and monitor Q3 earnings for direction.
Read full analysis

Key Stats

  • Market Cap
    $17.42B
  • Volume
    305,790
  • Sector
    Health
  • 52W High
    $630.19
  • 52W Low
    $393.42
  • Typical Hold Time
    14 Days
  • Enterprise Value
    $17.04B
  • Div Yield
    -
  • Trading Activity
    -
$599.51
52W Low: $393.42
23 Apr 2026
52W High: $630.19
22 Sep 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $393.42 and a high of $630.19, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Most Recent News

Content is generated by Aura AI

Delta CEO faces pressure as rivals poach elite flyers over Wi-Fi choice, Musk predicts job loss.

Delta Air Lines chose Amazon's Wi-Fi service over Elon Musk's Starlink, despite Musk's warnings that the decision would worsen passenger experience. Musk publicly predicted Delta CEO Ed Bastian would lose his job over this choice. Meanwhile, United a...

Market News
4 hours ago
24/7 Wall Street
Bearish
news icon
Delta CEO faces pressure as rivals poach elite flyers over Wi-Fi choice, Musk predicts job loss.

Oil prices drop sharply as EU considers releasing diesel and crude reserves to ease supply shortage

Oil prices fell significantly after reports that European Union member states are discussing a French proposal to release 50 million barrels of diesel and that International Energy Agency members might release 50 million barrels of crude oil. This mo...

Market News
4 hours ago
CNBC
Bearish
news icon
Oil prices drop sharply as EU considers releasing diesel and crude reserves to ease supply shortage

Paramount Resources targets 40,000 BOED production boost at Sinclair Montney by 2027

Paramount Resources is advancing a major project at Sinclair Montney aiming to increase production by 40,000 barrels of oil equivalent per day (BOED) by the end of fiscal 2027. Management's operational expertise and recent well tests indicate strong ...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Paramount Resources targets 40,000 BOED production boost at Sinclair Montney by 2027
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $17.42B
  • Volume
    305,790
  • Sector
    Health
  • 52W High
    $630.19
  • 52W Low
    $393.42
  • Typical Hold Time
    14 Days
  • Enterprise Value
    $17.04B
  • Div Yield
    -
  • Trading Activity
    -
$599.51
52W Low: $393.42
23 Apr 2026
52W High: $630.19
22 Sep 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $393.42 and a high of $630.19, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!